{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:07:25Z","timestamp":1788833245334,"version":"build-2803163510"},"reference-count":21,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Conventional pharmacovigilance identifies drug\u2013event reporting signals but not heterogeneity among anti\u2010HER2 cardiac dysfunction reports. We benchmarked this association using disproportionality analysis and assessed whether report\u2010level clustering added information beyond cardiovascular co\u2010reporting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed OpenVigil\/FAERS data. A separate openFDA analysis estimated overall, individual\u2010drug and drug\u2010group reporting odds ratios (RORs) and proportional reporting ratios (PRRs). The clustering cohort comprised 589 unique reports, grouped by cardiovascular co\u2010reporting and clustered using Gower distance\u2010based partitioning around medoids. Severe outcome comprised death, hospitalization, life\u2010threatening events or disability. Multivariable logistic regression and a nested likelihood\u2010ratio test compared conventional and cluster\u2010based models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Echocardiography\u2010related cardiac dysfunction was disproportionately reported with anti\u2010HER2 therapies overall (ROR 26.64, 95% CI 25.61\u201327.71; PRR 25.95, 95% CI 24.97\u201326.96) and across evaluated drugs and groupings. Among 589 reports, 383 (65.0%) had dysfunction only and 206 (35.0%) had cardiovascular co\u2010reporting; severe outcomes occurred in 17.5% and 41.7%, respectively (adjusted OR 3.24, 95% CI 2.14\u20134.95). Five clusters were retained. The LV dysfunction with cardiovascular co\u2010reporting cluster had the highest severe outcome proportion (52.0%) and higher adjusted odds than the ADC\u2010associated EF\u2010decline cluster (adjusted OR 4.18, 95% CI 1.55\u201311.68). Adding the cluster term improved model fit (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      = 11.34;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.023).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Conventional analyses confirmed a strong anti\u2010HER2 reporting signal and an association between cardiovascular co\u2010reporting and severe outcomes. The retained clusters added complementary report\u2010level resolution without constituting a validated clinical classification or prediction tool.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/bcp.70810","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:28:06Z","timestamp":1788830886000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti\u2010HER2 therapy\u2013associated echocardiography\u2010related cardiac dysfunction and severe outcomes: Comparison of disproportionality and report\u2010level cluster analyses"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5788-6522","authenticated-orcid":false,"given":"Junjie","family":"Liu","sequence":"first","affiliation":[{"name":"The Second School of Clinical Medicine Guangzhou Medical University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health Southern Medical University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Clinical School of Integrated Traditional Chinese and Western Medicine Guangzhou Medical University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixuan","family":"Liang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine Guangzhou Medical University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuofeng","family":"Wen","sequence":"additional","affiliation":[{"name":"The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University  Qingyuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijun","family":"Liu","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine Guangzhou Medical University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Yang","sequence":"additional","affiliation":[{"name":"The Third School of Clinical Medicine Guangzhou Medical University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Huang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine Guangzhou Medical University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ultrasound The Second Affiliated Hospital of Guangzhou Medical University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound The Second Affiliated Hospital of Guangzhou Medical University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0910383"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413513"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703643"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115022"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.5400"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18101510"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1288362"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058\u2010025\u201002013\u2010w"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.2307\/2528823"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316801"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0377\u20100427(87)90125\u20107"},{"key":"e_1_2_10_14_1","unstructured":"U.S. Food and Drug Administration.FDA Adverse Event Monitoring System (AEMS).https:\/\/www.fda.gov\/safety\/fda-adverse-event-monitoring-system-aems. Accessed July 29 2026."},{"key":"e_1_2_10_15_1","unstructured":"U.S. Food and Drug Administration.openFDA Drug Adverse Event API.https:\/\/open.fda.gov\/apis\/drug\/event\/. Accessed August 14 2026."},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.668"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16180"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912\u2010021\u201001114\u2010x"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549\u2010019\u201005303\u2010y"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.03.002"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2022.09.007"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70810","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bcp.70810","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:28:08Z","timestamp":1788830888000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/bcp.70810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":21,"alternative-id":["10.1002\/bcp.70810"],"URL":"https:\/\/doi.org\/10.1002\/bcp.70810","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"bcp.70810"}}